|
| Press Releases |
|
 |
|
| Thursday, June 23, 2022 |
|
|
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022). more info >> |
|
| Tuesday, June 14, 2022 |
|
|
Novotech's APAC and USA Leadership Teams at BIO 2022 |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will have key executives from APAC and the US attend BIO 2022 for meetings with biotechs considering the Asia-Pacific region to expedite their clinical trials. #4907 more info >> |
|
| Wednesday, June 15, 2022 |
|
|
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development |
| The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. more info >> |
|
| Monday, June 6, 2022 |
|
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 "Accelerating clinical development in China and the US". more info >> |
|
| Thursday, June 2, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US |
| Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US. more info >> |
|
| Thursday, May 12, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO China Summit 2022 event titled: Go/No Go Decisions Based on Early Phase Oncology Trials ('The Summit'). more info >> |
|
| Thursday, May 5, 2022 |
|
|
Novotech Acquires US CRO NCGS, Expands Global Expertise |
| Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of a service expansion program for its global base of clients. more info >> |
|
| Wednesday, February 9, 2022 |
|
|
Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report |
| Novotech, the leading Asia Pacific biotech specialist CRO, has been recognized as a top 10 CRO in the 2021 CenterWatch Global Site Relationship Benchmark Survey. more info >> |
|
| Wednesday, August 26, 2020 |
|
|
Novotech the Asia-Pacific CRO Leader - Awarded '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year' |
| Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year' in an overnight virtual global ceremony. This is the fourth consecutive year Novotech has been recognized with the prestigious CRO regional award. more info >> |
|
| Monday, July 13, 2020 |
|
|
Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can Tap the Region |
| The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focusses on how to advance oncology clinical trials in the Asia-Pacific which is currently attracting 10,000 oncology studies (GlobalData). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
APEL Products Shine on the World Stage:Redefining Health and Sustainability - A Roadmap to Transformative Impact 
Mar 10, 2025 21:22 HKT/SGT
|
|
|
Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time
Mar 10, 2025 20:24 JST
|
|
|
Entertainment Expo makes grand return
Mar 10, 2025 19:08 HKT/SGT
|
|
|
Hong Kong products highly rated by ASEAN e-shoppers
Mar 10, 2025 18:35 HKT/SGT
|
|
|
The New Economics of Power Markets in a Low-Carbon World 2025
Mar 10, 2025 18:20 HKT/SGT
|
|
|
CITIC Telecom CPC Wins Outstanding Award at 2025 Hong Kong Sustainable Development Innovation and Technology Awards
Mar 10, 2025 17:44 HKT/SGT
|
|
|
Big Ideas, Bold Leaders: Big CIO Show and Awards is Where Business Meets Innovation
Mar 10, 2025 16:41 HKT/SGT
|
|
|
DX Leaders Philippines 2025: Accelerating IT Innovation in a $40B Digital Economy
Mar 10, 2025 15:34 HKT/SGT
|
|
|
The PropertyGuru Asia Awards Malaysia in Partnership with iProperty return with 23 new categories in 2025
Mar 10, 2025 14:00 HKT/SGT
|
|
|
World's Most Sleep-Deprived Nation Has a Gender Crisis: Why Singaporean Women Bear the Heaviest Burden
Mar 10, 2025 13:00 HKT/SGT
|
|
|
uSMART Securities Surges 300% in Hong Kong Local Users
Mar 10, 2025 12:28 HKT/SGT
|
|
|
Hola Prime to Introduce Prime Academy for Personalized Trader Mentorship
Mar 10, 2025 12:00 HKT/SGT
|
|
|
CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC's AI
Mar 10, 2025 12:10 JST
|
|
|
Twin jewellery shows attract over 82,000 global buyers
Mar 9, 2025 13:19 HKT/SGT
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 20:26 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
